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SUMMARY 
 Recently, it was demonstrated under laboratory conditions that increased doses of LaSota vaccine 
increased ND antibody response significantly in chickens. In this study, we have used the same 
model to investigate whether vaccination with increased doses of lentogenic LaSota strain of 
Newcastle disease virus are associated with pathological changes in chickens. Four-week-old 
broiler chickens (n=100) were randomly assigned into four groups of 25 each: ZD, each drenched 
with phosphate-buffered saline, SD, DD and TD broilers were each drenched with single, double 
and triple dose of LaSota vaccine, respectively. The chickens were observed for clinical signs and 
lesions. Serum samples were collected from the chickens in all the groups at weekly intervals post 
inoculation (PV) and assayed for haemagglutination inhibition (HI) antibodies. The vaccinated 
broilers showed no morbidity and mortality. Only the bursa of all the vaccinated groups appeared 
slightly reduced in size on day 10 PV. The histopathological changes were lymphoid hyperplasia 
and formation of germinal centres in the spleen and caecal tonsils from days 3 to 6 PV and mild 
depletion of bursal lymphocytes on day 10 PV. Generally, the integrity of the lymphoid organs was 
intact. Groups DD and TD antibody titres were significantly (P < 0.05) higher than that of the SD 
on day 21 PV. This suggests that increased doses of LaSota vaccine does not cause pathologic 
impairment and may be considered in improving the performance of the vaccine in the control of 
velogenic ND.  
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INTRODUCTION 
Newcastle disease (ND), caused by virulent 
strains of avian orthoavulavirus-1 (formerly 




known as avian paramyxovirus-1, or Newcastle 
disease virus, NDV, used in this paper). The 
virus was recently classified to the genus 
Orthoavulavirus, subfamily Avulavirinae, family 




Paramyxoviridae and order Mononegavirales 
(Amarasinghe et al., 2019). ND is one of the 
most important poultry diseases around the 
globe, and often the cause of severe economic 
losses from morbidity, mortality, reduction in 
growth and egg production, and condemnation of 
carcasses in the poultry industry (Alexander et 
al., 2012; Amarasinghe et al., 2019). According 
to the World Organisation for Animal Health 
(OIE), ND is defined as an infection of birds by 
vNDV that are characterized by an intracerebral 
pathogenicity index (ICPI) in day-old chickens of 
0.7 or greater; or demonstration of multiple basic 
amino acids (either directly or by deduction) at 
the C-terminus of the F2 protein (at least three 
arginine or lysine residues between positions 113 
and 116) and phenylalanine at the N-terminus 
(position 117) of the F1 protein (OIE, 2012). 
Because of the highly contagious nature of NDV 
causing serious economic consequences to the 
poultry industry, as well as impacting the 
international trade of poultry and poultry 
products (and trade restrictions), the disease is 
reportable to the World Organization for Animal 
Health (OIE, 2012).  
Although there are different strains of the virus, 
pathotypes of ND defined by clinical signs in 
chickens after experimental inoculations were 
created to describe the virulence of ND strains 
and are classified into velogenic, mesogenic, 
lentogenic and asymptomatic (Alexander and 
Senne, 2008; Miller and Koch, 2013). These 
have varying virulence in the type and severity of 
the disease produced. Although all NDV strains 
belong to a single serotype (serotype 1), there is 
large genetic variability among NDV isolates. 
Strains are divided into 2 classes (I and II) based 
on molecular characterization, with class I 
composed of only 1 genotype (class I, genotype 
I) and with class II divided into 18 genotypes 
(class II, genotypes I–XVIII) (Diel et al., 2012a; 
Snoeck et al., 2013). While class I are mostly 
low pathogenic NDV strains (except for 1, 
APMV-1/chicken/Ireland48/90) (Alexander et 
al., 1992), found mainly in waterfowl, class II 
includes both virulent and avirulent strains 
(Miller et al., 2010; Afonso and Miller, 2013). 
The virulent ND is enzootic in Africa, a recurring 
concern to poultry industries (Bello et al., 2018), 
and causes disease in birds which manifests in 
respiratory and gastrointestinal and or nervous 
system symptoms (Miller and Koch, 2013; Igwe 
et al., 2018a). The lesions of ND have been 
reported to be dependent on the strain and dose 
or amount of virus received (Miller and Koch, 
2013). The velogenic pathotype causes systemic 
lesions, with necrosis and lymphocytic depletion 
(Igwe et al., 2018b). The mesogenic pathotype 
includes the moderately pathogenic which are 
also used in producing vaccines such as 
Komarov and Mukteswar, depending on the 
disease situation and national requirements (OIE, 
2012). They cause mainly the respiratory form of 
ND. The lentogenic and asymptomatic 
pathotypes referred to as low virulence are used 
as live vaccines (Miller and Koch, 2013).  
The primary strategy available to the poultry 
industry to control virulent NDV, the causative 
agent of ND, along with good biosecurity 
practises, is vaccination. Vaccines and vaccine 
programs have proven to be very beneficial for 
controlling diseases in domestic animals, as their 
widespread use has dramatically reduced the 
incidence of severe and fatal diseases (Roth, 
1999). Although many high-quality vaccines are 
commercially available for the control ND, the 
commonly used ND vaccines worldwide are live 
vaccine viruses of low virulence (lentogenic) that 
belong to genotype II (B1 and LaSota vaccines) 
(Kapczynski et al., 2013). LaSota vaccine has 
been used for years to provide protection from 
disease caused by virulent forms of the virus, 
referred to as mesogenic and velogenic NDV, 
and always used in countries where virulent 
NDV is endemic (Diel et al., 2012b; Dimitrov et 
al., 2017). Despite extensive vaccination with 
prophylactic vaccines and vaccination practises, 
outbreaks have been reported in vaccinated 
chickens in many parts of the world (Dimitrov et 
al., 2017; Bello et al., 2018), indicating that there 




is room for improvement in biosecurity measures 
and the current vaccine programs. However, 
creating an effective vaccine strategy poses many 
challenges.  
There is considerable controversy regarding the 
issue of vaccine failure on NDV control. It has 
been suggested that a better understanding of 
genetic variability of all strains of NDV and 
characteristics, is crucial for developing new 
vaccines and vaccination strategies (Dimitrov et 
al., 2017). Some suggest that vaccine failure is 
mainly caused by poor flock immunity due to 
inadequate vaccination and strict biosecurity 
practices and not antigenic variation between the 
vaccine strains and circulating field strains 
(Dortmans et al., 2012; Miller and Koch, 2013; 
Dimitrov et al., 2017). However, others have 
suggested that the use of higher doses of classical 
vaccines, which should induce higher antibody 
levels, would be enough to prevent ND caused 
by vNDV from genotypes more distant from 
vaccine strains (Cornax et al., 2012). Cornax et 
al. (2012) and Igwe et al. (2019) reported that to 
double the normal dose of LaSota vaccine will 
increase the level of antibody response in 
broilers; however, this cannot be easily 
recommended without finding out the likely 
adverse effect on the organs of chickens. This is 
because, a vaccine or vaccination protocol that 
lacks adverse reactions is very much needed by 
the poultry industry. The present study 
investigated the pathological changes from 
previously published studies (Igwe et al., 2019) 
in the organs of experimental commercial broiler 
chickens inoculated with varying doses of 
lentogenic strain (LaSota) of NDV.  
 
 
MATERIALS AND METHODS 
Broiler Chickens 
One hundred commercial Cobb broiler chicks 
(Gallus gallus domesticus) were purchased at 
one-day old from a reputable local commercial 
hatchery and randomly assigned into four groups 
of 25 broilers each. The parent stocks of the 
broilers were vaccinated against ND while the 
broilers were not vaccinated against any disease. 
They were kept in high security isolation in the 
departmental facility. Brooding was on deep 
litter. Feed and water were supplied ad libitum. 
General care of the birds was provided in 
accordance with the Institutional Animal Care 
and Use Committee, as outlined in the Guide for 
the Care and Use of Agricultural Animals in 
Research and Teaching 
(https://www.aaalac.org/about/Ag_Guide_3rd_ed
.pdf). 
LaSota Vaccine  
Live, freeze-dried lentogenic NDV (strain 
LaSota) vaccine manufactured and obtained from 
the National Veterinary Research Institute, Vom, 
Plateau State, Nigeria was used. It had a medium 
embryo infective dose (EID50) of 10
6.2 per ml. 
Vaccination 
At the age of four weeks, the randomly assigned 
four groups were named ZD (Zero dose) group, 
SD (Single dose) group, DD (Double dose) group 
and TD (Triple dose) group. Each broiler in the 
ZD group received 0.5 ml of the phosphate-
buffered saline (PBS) used in dissolving the 
vaccine orally as placebo. The SD broilers each 
was drenched with single dose of the vaccine in 
0.5 ml. Each of the broilers in groups DD and TD 
received double and triple doses of the vaccine in 
0.5 ml by drenching, respectively. 
Clinical and Pathology Examinations 
The chickens were observed twice daily for 
clinical signs from 0-day post-vaccination (PV) 
to 21 days PV.  Three chickens in each group 
were randomly selected and sacrificed by 
cervical dislocation. The sacrificed chickens 
were necropsied and examined for gross lesions 
on days 3, 6 and 10 PV. Samples of the bursa of 
Fabricius, spleen, thymus, lungs, kidney, liver 
and caecal tonsils, were fixed in 10% formal 
saline for minimum of 24 hours. The fixed 
tissues were trimmed and routinely processed 
before being embedded in paraffin wax. Sections 
(5 µm) were stained with haematoxylin and eosin 
(H&E) staining using the method of Suvarna et 




al. (2018). The slides were studied under the 
light microscope. 
Serology 
Blood samples (One ml of blood) were collected 
from 10 chickens in each group on days 0, 7, 14 
and 21 PV.  Each time different chickens were 
randomly selected. Sera were harvested and the 
humoral immune response was measured by the 
haemagglutination inhibition (HI) test using a 
suspension of LaSota vaccine in PBS as antigen 
at four haemagglutinating units according to the 
method of OIE (2012). Titres were calculated as 
the reciprocal of the last HI-positive serum 
dilution, and samples with HI titres of 3 (log2) 
and below were considered negative.  
Statistical Analysis 
The HI data were analysed using the one-way 
analysis of variance (ANOVA). Variant means 
were separated post hoc using the least 
significant difference method (Okafor, 1992). 
Statistical significance was defined as 5% level 




Clinical Signs  
No clinical sign was observed in all the groups of 
chickens throughout the experimental period 
(days 0 to 21 PV).  
Pathology 
Gross Pathology 
There were no abnormal gross findings in the 
organs of the chickens in all the vaccinated 
groups on days 3 and 6 PV (Plate 1 (A, B, C)), 
and throughout the experimental period for the 
spleen, thymus, caecal tonsils, kidney, liver and 
lungs. But there was only mild reduction in size 
of the bursa of Fabricius in all the vaccinated 
groups on day 10 PV (Plate 2 (A, B, C)). There 
were no abnormal gross findings in the control 
birds. 
Histopathology 
Histopathological sections of the bursa of 
Fabricius, spleen, thymus, lungs, kidney, liver 
and caecal tonsils showed normal architecture 
throughout the experimental period in all the 
groups. Histopathological sections of the bursa of 
Fabricius showed mild inflammatory cellular 
infiltration with normal lymphocytic population 
on day 3 PV in all the vaccinated groups (Plate 
3). Lymphoid hyperplasia and formation of 
germinal centres were common in the spleen and 
caecal tonsils from days 3 to 6 PV (Plates 4 and 
5) and increased markedly on day 10 PV in all 
the vaccinated groups. Mild depletion of 
lymphocytes which did not alter the normal 
architecture of the bursa was observed on day10 
PV in the SD, DD and TD groups. There were no 
histopathological findings in the control birds. 
Serology 
The pre-vaccination mean HI antibody titres to 
NDV of all the broilers was negative at 4-weeks 
old (day 0 post-vaccination). During the 
following weeks after vaccination, the HI titers 
increased progressively, reaching a moderately 
high level by day 14 post-vaccination. However, 
the HI antibody titres were significantly (P < 0.5) 
higher in the DD and TD groups than the SD on 
day 21 PV (Table 1). Throughout the experiment, 





The continuous threat of ND outbreaks in 
commercial poultry flocks in Nigeria necessitates 
vaccines and vaccination practises which will 
induce better flock immunity with minimal and 
negligible tissue damage along with strict 
biosecurity. Good biosecurity practise is a critical 
component of preventing the virus away from the 
flock before they achieve a protective level of 
immunity. Assessment of the protection attained 
in earlier study was based on antibody response 
only, as it was found that the development of 
satisfactory antibody levels or that increasing the 
dose of the LaSota vaccine will increase the level 
of antibody response in 





PLATE 2: Bursa of Fabricius of all 
groups showing a normal architecture, 
normal lymphocytic population, with 
mild inflammatory cells in vaccinated 
groups compared with ZD group on day 

















      
   
   
   
 
Plate 3: Spleen showing nodular 
hyperplasia of lymphoid cells and 
formation of germinal centres without 
evidence of necrosis in vaccinated groups 
compared with ZD group on day 3 PV. 
H&E, X400. 
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Plate 1: (A, B, C). Bursa 
of Fabricius, spleen and 
thymus of broilers on 
day 3 post-vaccination 
showing no difference in 
sizes. Plate 2: (A, B, C). 
Bursa of Fabricius, 
spleen and thymus of 
broilers on day10 PV. 
Note: only the bursa of 
Fabricius in all the 
vaccinated groups 
showed mild reduction in 
size than the ZD group. 





Plate 4: Caecal tonsils showing nodular 
hyperplasia of lymphoid cells without 
evidence of necrosis in vaccinated groups 
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would be pathological changes on the organs of 
commercial chickens experimentally vaccinated 
with varying doses of live lentogenic strain 
(LaSota) of NDV. 
Clinically, our results showed that all the 
chickens vaccinated with higher doses of LaSota 
exhibited no signs of disease. This finding is 
consistent with previous observations using 
lentogenic strains (Ulster, B1, QV4 and LaSota) 
(Gough and Allan 1976; Brown et al., 1999; 
Kapczynski and King, 2005; Cornax et al., 2012; 
Igwe et al., 2019). Our observation showed that 
the LaSota vaccine induced much better clinical  
 
protection from vaccine reactions regardless of 
the varying doses administered.  The absence of 
clinical reactions to LaSota vaccination in this 
study is in agreement with the strategy to use less 
virulent strains that reduce disease rates after 
vaccination as the seed viruses for vaccine 
production (van Boven et al., 2008). 
 
The only gross finding in chickens in all the 
vaccinated groups with LaSota was moderate 
reduction in size of the bursa at day 10 PV. 
Results of various investigators with LaSota or 
other commercial vaccine strains using single 
dose, while consistent, do vary somewhat, 
particularly in the occurrence of organ vaccinal 
reactions. Winterfield et al. (1980) did not 
observe any gross lesions in chickens inoculated 
with LaSota via the eye drop. Hamid et al. 
(1990) observed only moderate enlargement of  
 
the spleen and slight swelling of the bursa on day 
4 after oro-nasal infection with the lentogenic V4 
strain of NDV in seven-week-old commercial 
White Leghorn chickens. Brown et al., 1999 
reported only moderate reddening of the thymus 




Zero dose group Single dose group Double dose group Triple dose group 
0 3.2 ± 0.33a 3.6 ±0.78 a 3.6 ±0.78 a 3.2 ±0.33 a 
7 0 ±0.00 a 137.6 ±32.37 a 300.8 ±123.22 a 275.2 ±125.14 a 
14 0 ±0.00 a 435.2 ±129.70 b 678.4 ±101.06 b 537.6 ±133.30 b 
21 0 ±0.00 a 665.6 ±78.21 b 1536 ±170.67 c 1433.6 ±167.22 c 
Note: a, b, c Different superscripts in a row indicate significant differences between the groups (P < 0.05) 
 




on day 5 post infection in chickens inoculated 
with lentogenic isolates (B1 and QV4) via the 
conjunctival sac. Other investigators have 
determined that poultry infected with lentogenic 
NDV are more susceptible to secondary 
respiratory infections that cause disease 
considering that viral replication and subsequent 
compromise of air sac epithelium could be a 
mechanism allowing for entry for secondary 
agents (Ficken et al., 1987; Nakamura et al., 
1994). While it is not possible to explain all the 
differences, it is known that different 
breeds/strains of birds vary in their responses to 
vaccination (Abdul-Aziz and Arp, 1983; Seal et 
al., 2000; Dalgaard et al., 2010). In addition, 
genetic background of a host determines how the 
immune response to a given microorganism will 
evolve (Sharma, 2013). Grossly, our results 
supported and correlate with the absence of 
clinical signs and results of the HI tests and from 
previous findings suggesting that where the 
LaSota vaccine is used for either primary or 
secondary vaccination, even at increased doses, 
excellent organs and respiratory tract protection 
will be apparent and can minimize susceptibility 
to secondary respiratory infections that cause 
disease. 
The histopathological findings of normal 
architecture throughout the experimental period 
in all the groups clearly show that the broiler 
chickens responded well to a primary inoculation 
of LaSota vaccine administered in varying doses. 
Mild inflammatory cellular infiltration of the 
bursa was seen on day 3 PV in all the vaccinated 
groups. The immune system of birds is 
functionally divided into an early responding, 
innate and a slow-reacting adaptive immune 
system, which are essential and cooperate for 
antimicrobial, primary and vaccination-induced 
immunity. Due to their ability to replicate in the 
host, live vaccines induce a variety of innate and 
adaptive immune responses (Schijns et al., 
2008). It has been suggested that innate 
immunity can play an important role against 
NDV infection (Rohollahzadeh et al., 2018). 
Studies also confirmed that innate defence 
system is necessary for vaccination-induced 
immunity (Schijns et al., 2008). Innate immune 
cells include epithelial cell, macrophages, 
dendritic cells, various granulocytes and natural 
killer cells. They are able to respond within 
minutes, until adaptive responses (B and T cell 
mediated) become mobilized, and are also likely 
to play an important role in the early onset of 
immunity associated with live vaccines that not 
only prevent disease of the individual bird but 
also limit virus transmission  (Jeurissen et al., 
2000; Schijns et al., 2008). Our results indicated 
that mild local and systemic reactions to vaccines 
are to be expected as a natural consequence of 
stimulating the immune system (Hammer, 1974; 
Schijns et al. 2008). Evidence of lymphoid 
hyperplasia was observed in the spleen and 
caecal tonsils of birds in all the vaccinated 
groups regardless of the doses administered, 
suggesting that LaSota vaccine is immunogenic 
and protective. Live NDV vaccines based on the 
LaSota strain have been studied for many years. 
Early trials suggested that such vaccines were 
immunogenic and protective (Westbury, 1981). 
This finding of the present study shows that 
increased doses of LaSota vaccine exerts a 
significant boosting effect and correlates with the 
HI titers of broiler chickens observed in earlier 
studies (Cornax et al., 2012; Igwe et al., 2019). It 
is also in agreement with the report of Hamid et 
al. (1990), who reported that the chief 
histological changes observed in the 
lymphoreticular system were the formation of 
new germinal centres with a peak on the third 
week after infection in spleen and the cortex and 
medulla of the bursa probably indicate the 
presence and processing of antigen. However, in 
the present study, lymphoid hyperplasia was 
observed in the spleen and caecal tonsils as we 
only relied on necropsies at days 3, 6 and 10 with 
daily clinical and weekly serological 
observations at the terminations of the study at 
21 days PV. Mild depletion of lymphocytes 
which did not alter the normal architecture of the 




bursa was observed on day10 PV in the SD, DD 
and TD groups suggesting that mild lymphocytic 
depletion of the bursa may occur following 
vaccination of chickens with lentogenic NDV 
pathotypes. Vaccination for NDV is primarily by 
mass application of live-virus vaccines among 
commercial poultry. Although protection is 
measured by presence of antibodies to NDV, 
vaccinated B-cell depleted chickens are resistant 
to disease. Consequently, immune protection 
involves responses that are presently 
incompletely defined (Seal et al., 2000). 
Interestingly, we found that increased doses of 
LaSota vaccine in chickens was associated with 
lymphoid hyperplasia and no decrease in HI 
titres in bursa mildly depleted vaccinated groups, 
compared with unvaccinated group. These results 
revealed that although antibody responses 
induced by live vaccines are the key modulators 
of protection, adaptive immune response is also 
an important mediator of protection against 
intracellular pathogens (Sharma, 2013).  
 
CONCLUSION 
In conclusion, increased doses of lentogenic 
LaSota strain of Newcastle disease virus 
inoculation in broilers caused moderate reduction 
in size of the bursa. Histopathological changes 
included lymphoid hyperplasia and formation of 
germinal centres in the spleen and caecal tonsils. 
Clinically our results suggest that increased doses 
of LaSota has met the goal of current vaccination 
procedures, which is, to induce protective 
immunity while producing a minimal 
antagonistic response in the bird. For the poultry 
producer, this decreases economic losses at 
harvest. The presented study supported and 
extended previous findings regarding the safety 
of increased doses of LaSota vaccine in chickens. 
This suggests that doubling the dose of LaSota 
vaccine does not cause pathologic impairment 
and may be considered in improving the 
performance of the vaccine in the control of 
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